Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2024Indian Journal of Pharmaceutical Education and ResearchOpen Access

Chlorogenic Acid, a Potential Glucose-6-Phosphatase Inhibitor: An Approach to Develop a Pre-Clinical Glycogen Storage Disease Type I Model

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSantosh B. PatilKLE UniversityPGPramod C. GadadKES College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Patil et al. (2024) studied this question.

synapsesocial.com/papers/68e680fab6db64358760a0c7https://doi.org/10.5530/ijper.58.2s.40
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New enzymatic method for serum uric acid at 500 nm.1978 · 130 citations
  2. 2Dietary dilemmas in the management of glycogen storage disease type I2011 · 50 citations
  3. 3Determination of Uric Acid in Serum, with Use of Uricase and a Tribromophenol—Aminoantipyrine Chromogen1973 · 107 citations
  4. 4Contribution of Chlorogenic Acids to the Inhibition of Human Hepatic Glucose-6-phosphatase Activity in Vitro by Svetol, a Standardized Decaffeinated Green Coffee Extract2010 · 81 citations
  5. 5The Specificity of Glucose 6-Phosphatase of Intact Liver Microsomes1972 · 162 citations